CompletedPhase 2/3

Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo

Thailand20 participantsStarted 2021-06-01

Plain-language summary

Use of the oral desogestrel compared with placebo for preoperative treatment of endometrioma in the patient who underwent to surgery in next 3 months The result will be evaluated on cyst diameter, the associated pain and side effect of the oral desogestrel.

Who can participate

Age range15 Years – 49 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Thai female and foreigner who can understand Thai language * Age 15-49 years * Diagnose as endometrioma sized more than 3 cm * Underwent to surgery in next 13 weeks Exclusion Criteria: * History of endometriosis * Pregnancy woman * Contraindication for desogestrel : History of thrombotic event, Autoimmune disease,gestational trophoblastic disease * Ovarian endometrioma with complications : Ruptured, twisted * Contraindications for NSAIDs : Peptic ulcer, thrombocytopenia, liver disease * History of hormonal treatment for endometrioma : DMPA,OCP, GNRH agonist/antoginist

What they're measuring

Cyst diameter

Timeframe: 3 months after drug given

Trial details

NCT IDNCT04941833

SponsorDepartment of Medical Services Ministry of Public Health of Thailand

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2022-07-31

View on ClinicalTrials.gov More Endometrioma trials